What could health technology assessment learn from living clinical practice guidelines?
A “living” approach to clinical practice guidelines is when the identification, appraisal and synthesis of evidence is maintained and repeated at an agreed frequency, with a clear process for when and how new evidence is to be incorporated. The value of a living approach to guidelines was emphasised...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1234414/full |
| _version_ | 1797737258870112256 |
|---|---|
| author | Saskia Cheyne Saskia Cheyne Samantha Chakraborty Samara Lewis Sue Campbell Tari Turner Sarah Norris Sarah Norris |
| author_facet | Saskia Cheyne Saskia Cheyne Samantha Chakraborty Samara Lewis Sue Campbell Tari Turner Sarah Norris Sarah Norris |
| author_sort | Saskia Cheyne |
| collection | DOAJ |
| description | A “living” approach to clinical practice guidelines is when the identification, appraisal and synthesis of evidence is maintained and repeated at an agreed frequency, with a clear process for when and how new evidence is to be incorporated. The value of a living approach to guidelines was emphasised during the COVID-19 pandemic when health professionals and policymakers needed to make decisions regarding patient care in the context of a nascent but rapidly evolving evidence base. In this perspective, we draw on our recent experience developing Australian and international living guidelines and reflect on the feasibility of applying living guideline methods and processes to a lifecycle approach to health technology assessment (HTA). We believe the opportunities and challenges of adopting a living approach in HTA fall into five key themes: identification, appraisal and synthesis of evidence; optimising the frequency of updates; embedding ongoing multi-stakeholder engagement; linking the emergence of new evidence to reimbursement; and system capacity to support a living approach. We acknowledge that the suitability of specific living approaches to HTA will be heavily influenced by the type of health technology, its intended use in the health system, local reimbursement pathways, and other policy settings. But we believe that the methods and processes applied successfully to guideline development to manage evidentiary uncertainty could be applied in the context of HTA and reimbursement decision-making to help manage similar sources of uncertainty. |
| first_indexed | 2024-03-12T13:26:02Z |
| format | Article |
| id | doaj.art-fa3397f99ce541628e769a6a07f4448c |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-03-12T13:26:02Z |
| publishDate | 2023-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-fa3397f99ce541628e769a6a07f4448c2023-08-25T07:18:41ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-08-011410.3389/fphar.2023.12344141234414What could health technology assessment learn from living clinical practice guidelines?Saskia Cheyne0Saskia Cheyne1Samantha Chakraborty2Samara Lewis3Sue Campbell4Tari Turner5Sarah Norris6Sarah Norris7Faculty of Medicine and Health, University of Sydney, Sydney, NSW, AustraliaAustralian Living Evidence Consortium, Cochrane Australia, Monash University, Melbourne, VIC, AustraliaAustralian Living Evidence Consortium, Cochrane Australia, Monash University, Melbourne, VIC, AustraliaHereco, Sydney, NSW, AustraliaHereco, Sydney, NSW, AustraliaAustralian Living Evidence Consortium, Cochrane Australia, Monash University, Melbourne, VIC, AustraliaFaculty of Medicine and Health, University of Sydney, Sydney, NSW, AustraliaHereco, Sydney, NSW, AustraliaA “living” approach to clinical practice guidelines is when the identification, appraisal and synthesis of evidence is maintained and repeated at an agreed frequency, with a clear process for when and how new evidence is to be incorporated. The value of a living approach to guidelines was emphasised during the COVID-19 pandemic when health professionals and policymakers needed to make decisions regarding patient care in the context of a nascent but rapidly evolving evidence base. In this perspective, we draw on our recent experience developing Australian and international living guidelines and reflect on the feasibility of applying living guideline methods and processes to a lifecycle approach to health technology assessment (HTA). We believe the opportunities and challenges of adopting a living approach in HTA fall into five key themes: identification, appraisal and synthesis of evidence; optimising the frequency of updates; embedding ongoing multi-stakeholder engagement; linking the emergence of new evidence to reimbursement; and system capacity to support a living approach. We acknowledge that the suitability of specific living approaches to HTA will be heavily influenced by the type of health technology, its intended use in the health system, local reimbursement pathways, and other policy settings. But we believe that the methods and processes applied successfully to guideline development to manage evidentiary uncertainty could be applied in the context of HTA and reimbursement decision-making to help manage similar sources of uncertainty.https://www.frontiersin.org/articles/10.3389/fphar.2023.1234414/fullclinical practical guidelineshealth technolgy assessmentliving systematic review (LSR)regulatory policies and structuresreimbursement pathwayslifecycle HTA |
| spellingShingle | Saskia Cheyne Saskia Cheyne Samantha Chakraborty Samara Lewis Sue Campbell Tari Turner Sarah Norris Sarah Norris What could health technology assessment learn from living clinical practice guidelines? Frontiers in Pharmacology clinical practical guidelines health technolgy assessment living systematic review (LSR) regulatory policies and structures reimbursement pathways lifecycle HTA |
| title | What could health technology assessment learn from living clinical practice guidelines? |
| title_full | What could health technology assessment learn from living clinical practice guidelines? |
| title_fullStr | What could health technology assessment learn from living clinical practice guidelines? |
| title_full_unstemmed | What could health technology assessment learn from living clinical practice guidelines? |
| title_short | What could health technology assessment learn from living clinical practice guidelines? |
| title_sort | what could health technology assessment learn from living clinical practice guidelines |
| topic | clinical practical guidelines health technolgy assessment living systematic review (LSR) regulatory policies and structures reimbursement pathways lifecycle HTA |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1234414/full |
| work_keys_str_mv | AT saskiacheyne whatcouldhealthtechnologyassessmentlearnfromlivingclinicalpracticeguidelines AT saskiacheyne whatcouldhealthtechnologyassessmentlearnfromlivingclinicalpracticeguidelines AT samanthachakraborty whatcouldhealthtechnologyassessmentlearnfromlivingclinicalpracticeguidelines AT samaralewis whatcouldhealthtechnologyassessmentlearnfromlivingclinicalpracticeguidelines AT suecampbell whatcouldhealthtechnologyassessmentlearnfromlivingclinicalpracticeguidelines AT tariturner whatcouldhealthtechnologyassessmentlearnfromlivingclinicalpracticeguidelines AT sarahnorris whatcouldhealthtechnologyassessmentlearnfromlivingclinicalpracticeguidelines AT sarahnorris whatcouldhealthtechnologyassessmentlearnfromlivingclinicalpracticeguidelines |